Drugs.com: Effect of cancer treatment on COVID-19 mortality

A UC study sheds light on death rates as they relate to patients with cancer and COVID-19

Cancer patients treated one to three months prior to COVID-19 diagnosis and those treated with chemoimmunotherapy have the highest 30-day mortality, according to a study presented at the annual meeting of the European Society for Medical Oncology, held virtually from Sept. 19 to 21.

Lead author Trisha Wise-Draper, MD, PhD, associate professor of medicine, UC Health oncologist and member of the UC Cancer Center, and colleagues examined outcomes related to systemic cancer treatment within one year of laboratory-confirmed severe acute respiratory syndrome coronavirus 2 infection. 

Read the full Drugs.com/HealthDay News story.

Read the full UC News story.

Featured photo courtesy of the National Cancer Institute.

Next Lives Here

The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's graduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.

Related Stories

2

Ohio could soon make breast cancer screenings more affordable

May 9, 2025

The University of Cincinnati Cancer Center's Ann Brown was featured in Local 12 and Cincinnati Enquirer reports on a bill introduced by Rep. Jean Schmidt in the Ohio legislature that seeks to eliminate out of pocket medical expenses such as copays and deductibles associated with supplemental breast cancer screenings.

3

Preparing students for artificial intelligence in education

May 8, 2025

Laurah Turner, PhD, associate dean for artificial intelligence and educational informatics at the University of Cincinnati's College of Medicine, recently joined the For The Love of EdTech podcast to discuss the usage of personalized learning and AI coaches to enhance educational experiences.

Debug Query for this